Dr. Vietz is vice president and head of regulatory affairs at Foundation Medicine, a world-leading molecular insights company connecting physicians and their patients to the latest cancer treatment approaches. She is accountable for modular premarket approval submissions, writing and leading pre-submission discussions with the U.S. Food and Drug Administration (FDA), and investigational device exemption submissions. She has led submission and authored documents for the FDA’s Expedited Access Pathway Program and parallel review requests. 

Dr. Vietz received her bachelor’s degree in chemical engineering and her Ph.D. in biomedical/medical engineering from the University of Rochester.